Methyl Renew
90/100
This product looks safe
- Contains proprietary blend — exact ingredient amounts not disclosed
- 80% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed
Label Data
1 Tablet(s)
Serving Size
Other Combinations
Product Type
80%
Evidence Coverage
Supplement Facts — Evidence Check
20 mg
(100% DV)
✅ 1.4× RDA — within safe limits
📚 193 studies (Tier A: 5, B: 63)
500 mcg
(125% DV)
✅ 1.2× RDA — within safe limits
📚 225 studies (Tier A: 10, B: 105)
500 mcg
(8333% DV)
📊 208.3× RDA — above typical dose
📚 138 studies (Tier A: 1, B: 44)
2000 mcg
(667% DV)
📊 66.7× RDA — above typical dose
📚 26 studies (Tier A: 0, B: 11)
Proprietary Blend
415 mg
Other Ingredients
Microcrystalline Cellulose
Stearate
Stearic Acid
Magnesium Stearate
Label Claims — Verification
❓
All Other
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
⚠️ Warnings & Precautions
KEEP OUT OF REACH OF CHILDREN.
TAMPER RESISTANT OUTER SEAL - DO NOT USE IF BROKEN.
Additional Information
Product #2800-06
FOR DISTRIBUTION BY HEALTH CARE PROFESSIONALS ONLY.
Store in cool, dry place. Best if kept refrigerated.
Functional Health Series
"When You Want The Best"
302028 MFG02/2013
Product Details
DSLD Entry Date
2013-11-25
Product Type
Other Combinations
Form
Tablet or Pill
Brand
Nutri-West
DSLD ID
28024
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100